Alimera Sciences Inc. [NASDAQ: ALIM] gained 75.87% on the last trading session, reaching $5.54 price per share at the time.
If compared to the average trading volume of 97.25K shares, ALIM reached a trading volume of 7222706 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about Alimera Sciences Inc. [ALIM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ALIM shares is $7.38 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALIM stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Alimera Sciences Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 25, 2024. The new note on the price target was released on October 30, 2023, representing the official price target for Alimera Sciences Inc. stock.
The Average True Range (ATR) for Alimera Sciences Inc. is set at 0.38, with the Price to Sales ratio for ALIM stock in the period of the last 12 months amounting to 3.22. The Price to Book ratio for the last quarter was 7.14, with the Price to Cash per share for the same quarter was set at 0.27.
Trading performance analysis for ALIM stock
Alimera Sciences Inc. [ALIM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 74.76. With this latest performance, ALIM shares gained by 84.67% in over the last four-week period, additionally plugging by 48.92% over the last 6 months – not to mention a rise of 97.15% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ALIM stock in for the last two-week period is set at 84.08, with the RSI for the last a single of trading hit 89.70, and the three-weeks RSI is set at 78.61 for Alimera Sciences Inc. [ALIM]. The present Moving Average for the last 50 days of trading for this stock 3.34, while it was recorded at 3.61 for the last single week of trading, and 3.51 for the last 200 days.
Alimera Sciences Inc. [ALIM]: A deeper dive into fundamental analysis
Alimera Sciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.51 and a Current Ratio set at 2.62.
An analysis of Institutional ownership at Alimera Sciences Inc. [ALIM]
The top three institutional holders of ALIM stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in ALIM stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in ALIM stock with ownership which is approximately 5.8386%.
